X0306
4
2018-12-06
0
0001717452
Odonate Therapeutics, Inc.
ODT
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
1
1
1
0
Chief Executive Officer
0001191935
TANG CAPITAL PARTNERS LP
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
0
1
0
0001232621
TANG CAPITAL MANAGEMENT LLC
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
0
1
0
0001495904
Lemkey John G
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
1
0
0
Chief Operating Officer
0001759910
Hearne Michael S
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Common Stock
2018-12-06
4
P
0
10000
14.6243
A
12752338
I
By LP
Common Stock
2018-12-06
4
P
0
500
14.6598
A
12752838
I
By LP
Common Stock
2018-12-07
4
P
0
9500
14.978
A
12762338
I
By LP
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.44 to $15.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 4 herein.
The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management,
LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of
common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority
to vote such shares. John Lemkey is the Chief Operating Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Michael Hearne is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Financial Officer of TCM. Mr. Tang, Mr. Lemkey and Mr. Hearne each have a pecuniary interest in a portion of the shares beneficially held by TCP.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.60 to $14.69.
The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.74 to $15.00.
/s/ Kevin Tang
2018-12-10
/s/ Kevin Tang, Managing Member of Tang Capital Management, LLC, General Partner
2018-12-10
/s/ Kevin Tang, Managing Member
2018-12-10
/s/ John Lemkey
2018-12-10
/s/ John Lemkey, as attorney-in-fact for Michael Hearne
2018-12-10